Athanor Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Athanor Capital’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,547	Closed	-$710K	–	993
2020 Q4	$710K	Buy	+11,547	New	+$453K	0.02%	390

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Athanor Capital's PMVP Position: Q1 2021 in Review

Athanor Capital sold out of PMV Pharmaceuticals (PMVP) in Q1 2021, closing a stake of 11,547 shares — an estimated $710K sold.

Athanor Capital first reported a position in PMVP in Q4 2020 and held it in 1 quarter. The position peaked at $710K in Q4 2020. 81 funds tracked by Wall St. Rank hold PMVP as of Q1 2021.

Athanor Capital reported no remaining PMV Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Athanor Capital sold 11,547 PMV Pharmaceuticals shares in Q1 2021, an estimated $710K.
Athanor Capital first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 1 quarter.
Athanor Capital's PMV Pharmaceuticals position peaked at $710K in Q4 2020.
81 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.